when was tirzepatide approved Day 4: Zepbound (Tirzepatide – weight loss indication) FDA Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management

Zepbound interactions: What to avoid and more Something New. Something More Effective. We're excited to now offer Tirzepatide as part of our medically supervised weight loss program. Why this matters: Targets both GLP 1 & GIP pathways Supports Microdosing tirzepatide is an emerging approach for supporting metabolic and hormonal health. By using smaller, carefully titrated doses, some patients may experience improved insulin sensitivity, reduced inflammation, and better metabolic regulation. For Tirzepatide (Mounjaro, Zepbound) + Cannabis Interaction Pharmacist Reviewed InteractSafe